446 related articles for article (PubMed ID: 17947611)
1. Clarithromycin targets neutrophilic airway inflammation in refractory asthma.
Simpson JL; Powell H; Boyle MJ; Scott RJ; Gibson PG
Am J Respir Crit Care Med; 2008 Jan; 177(2):148-55. PubMed ID: 17947611
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Vagaggini B; Paggiaro P
Ann Allergy Asthma Immunol; 2010 Jun; 104(6):464-70. PubMed ID: 20568377
[TBL] [Abstract][Full Text] [Related]
3. Neutrophilic inflammation and CXC chemokines in patients with refractory asthma.
Kikuchi S; Kikuchi I; Takaku Y; Kobayashi T; Hagiwara K; Kanazawa M; Nagata M
Int Arch Allergy Immunol; 2009; 149 Suppl 1():87-93. PubMed ID: 19494512
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.
Gibson PG; Simpson JL; Saltos N
Chest; 2001 May; 119(5):1329-36. PubMed ID: 11348936
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma.
Hrvacić B; Bosnjak B; Bosnar M; Ferencić Z; Glojnarić I; Eraković Haber V
Eur J Pharmacol; 2009 Aug; 616(1-3):236-43. PubMed ID: 19560456
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma.
Amayasu H; Yoshida S; Ebana S; Yamamoto Y; Nishikawa T; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Ishizaki Y
Ann Allergy Asthma Immunol; 2000 Jun; 84(6):594-8. PubMed ID: 10875487
[TBL] [Abstract][Full Text] [Related]
7. Health effects of acute exposure to air pollution. Part I: Healthy and asthmatic subjects exposed to diesel exhaust.
Holgate ST; Sandström T; Frew AJ; Stenfors N; Nördenhall C; Salvi S; Blomberg A; Helleday R; Söderberg M
Res Rep Health Eff Inst; 2003 Dec; (112):1-30; discussion 51-67. PubMed ID: 14738208
[TBL] [Abstract][Full Text] [Related]
8. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.
Simpson JL; Scott RJ; Boyle MJ; Gibson PG
Am J Respir Crit Care Med; 2005 Sep; 172(5):559-65. PubMed ID: 15901607
[TBL] [Abstract][Full Text] [Related]
9. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
Brusselle GG; Vanderstichele C; Jordens P; Deman R; Slabbynck H; Ringoet V; Verleden G; Demedts IK; Verhamme K; Delporte A; Demeyere B; Claeys G; Boelens J; Padalko E; Verschakelen J; Van Maele G; Deschepper E; Joos GF
Thorax; 2013 Apr; 68(4):322-9. PubMed ID: 23291349
[TBL] [Abstract][Full Text] [Related]
11. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
[TBL] [Abstract][Full Text] [Related]
12. Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma.
Kikuchi S; Nagata M; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():7-11. PubMed ID: 15947478
[TBL] [Abstract][Full Text] [Related]
13. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum: association with asthma severity and eosinophilic inflammation.
Aggarwal S; Moodley YP; Thompson PJ; Misso NL
Clin Exp Allergy; 2010 Jan; 40(1):85-93. PubMed ID: 19895589
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of the airway inflammation and the relationship to interleukin-17 in severe asthma].
Zhou QT; Sun YC; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):630-4. PubMed ID: 16207434
[TBL] [Abstract][Full Text] [Related]
16. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?
Bullens DM; Truyen E; Coteur L; Dilissen E; Hellings PW; Dupont LJ; Ceuppens JL
Respir Res; 2006 Nov; 7(1):135. PubMed ID: 17083726
[TBL] [Abstract][Full Text] [Related]
17. Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma.
Wood LG; Powell H; Gibson PG
Clin Exp Allergy; 2010 Feb; 40(2):232-41. PubMed ID: 19878195
[TBL] [Abstract][Full Text] [Related]
18. Role of neutrophils in persistent airway obstruction due to refractory asthma.
Choi JS; Jang AS; Park JS; Park SW; Paik SH; Park JS; Uh ST; Kim YH; Park CS
Respirology; 2012 Feb; 17(2):322-9. PubMed ID: 22040093
[TBL] [Abstract][Full Text] [Related]
19. The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.
Banerjee D; Honeybourne D; Khair OA
Treat Respir Med; 2004; 3(1):59-65. PubMed ID: 15174894
[TBL] [Abstract][Full Text] [Related]
20. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
Nair P; Pizzichini MM; Kjarsgaard M; Inman MD; Efthimiadis A; Pizzichini E; Hargreave FE; O'Byrne PM
N Engl J Med; 2009 Mar; 360(10):985-93. PubMed ID: 19264687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
